tiprankstipranks
Trending News
More News >
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
India Market

Akums Drugs and Pharmaceuticals Limited (AKUMS) Ratios

Compare
4 Followers

Akums Drugs and Pharmaceuticals Limited Ratios

IN:AKUMS's free cash flow for Q4 2024 was ₹0.33. For the 2024 fiscal year, IN:AKUMS's free cash flow was decreased by ₹ and operating cash flow was ₹0.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.55 1.60 1.52
Quick Ratio
1.78 1.08 0.94
Cash Ratio
0.11 0.09 0.04
Solvency Ratio
0.47 0.04 0.08
Operating Cash Flow Ratio
0.52 0.41 0.14
Short-Term Operating Cash Flow Coverage
34.07 1.21 0.42
Net Current Asset Value
₹ ―₹ 12.25B₹ -8.55B₹ -6.19B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.16 0.19
Debt-to-Equity Ratio
0.03 0.80 0.86
Debt-to-Capital Ratio
0.03 0.44 0.46
Long-Term Debt-to-Capital Ratio
0.00 0.10 0.14
Financial Leverage Ratio
1.35 4.96 4.55
Debt Service Coverage Ratio
11.97 0.38 0.55
Interest Coverage Ratio
10.22 7.16 4.16
Debt to Market Cap
<0.01 0.04 0.04
Interest Debt Per Share
7.93 42.71 42.25
Net Debt to EBITDA
-0.02 3.48 1.84
Profitability Margins
Gross Profit Margin
39.43%35.76%33.59%
EBIT Margin
9.23%0.12%5.65%
EBITDA Margin
13.00%3.25%8.89%
Operating Profit Margin
7.63%8.95%5.51%
Pretax Profit Margin
8.48%-1.13%4.33%
Net Profit Margin
8.31%-0.10%2.73%
Continuous Operations Profit Margin
8.44%0.02%2.82%
Net Income Per EBT
97.95%8.91%63.11%
EBT Per EBIT
111.14%-12.58%78.56%
Return on Assets (ROA)
8.22%-0.11%2.90%
Return on Equity (ROE)
11.10%-0.57%13.23%
Return on Capital Employed (ROCE)
9.65%15.61%9.56%
Return on Invested Capital (ROIC)
9.55%-0.23%5.12%
Return on Tangible Assets
8.24%-0.12%2.91%
Earnings Yield
4.78%-0.04%0.76%
Efficiency Ratios
Receivables Turnover
5.23 4.82 4.08
Payables Turnover
3.84 4.85 4.07
Inventory Turnover
3.62 4.10 3.16
Fixed Asset Turnover
2.60 2.89 2.87
Asset Turnover
0.99 1.14 1.06
Working Capital Turnover Ratio
3.86 5.79 5.44
Cash Conversion Cycle
75.40 89.61 115.27
Days of Sales Outstanding
69.76 75.71 89.55
Days of Inventory Outstanding
100.80 89.11 115.44
Days of Payables Outstanding
95.15 75.22 89.71
Operating Cycle
170.55 164.82 204.99
Cash Flow Ratios
Operating Cash Flow Per Share
31.09 34.58 11.22
Free Cash Flow Per Share
12.89 12.97 -9.67
CapEx Per Share
18.20 21.61 20.89
Free Cash Flow to Operating Cash Flow
0.41 0.38 -0.86
Dividend Paid and CapEx Coverage Ratio
1.71 1.60 0.54
Capital Expenditure Coverage Ratio
1.71 1.60 0.54
Operating Cash Flow Coverage Ratio
5.27 0.88 0.29
Operating Cash Flow to Sales Ratio
0.11 0.12 0.05
Free Cash Flow Yield
2.73%1.63%-1.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.92 -2.84K 132.12
Price-to-Sales (P/S) Ratio
1.74 2.85 3.61
Price-to-Book (P/B) Ratio
2.32 16.17 17.47
Price-to-Free Cash Flow (P/FCF) Ratio
36.67 61.41 -82.36
Price-to-Operating Cash Flow Ratio
15.21 23.03 70.95
Price-to-Earnings Growth (PEG) Ratio
>-0.01 27.18 -0.96
Price-to-Fair Value
2.32 16.17 17.47
Enterprise Value Multiple
13.34 91.33 42.38
Enterprise Value
70.61B 119.29B 131.00B
EV to EBITDA
13.34 91.33 42.38
EV to Sales
1.73 2.97 3.77
EV to Free Cash Flow
36.61 63.84 -86.09
EV to Operating Cash Flow
15.18 23.94 74.17
Tangible Book Value Per Share
204.08 49.38 45.45
Shareholders’ Equity Per Share
203.66 49.23 45.57
Tax and Other Ratios
Effective Tax Rate
<0.01 1.02 0.35
Revenue Per Share
272.11 278.94 220.77
Net Income Per Share
22.60 -0.28 6.03
Tax Burden
0.98 0.09 0.63
Interest Burden
0.92 -9.10 0.77
Research & Development to Revenue
0.00 0.00 0.00
SG&A to Revenue
0.01 0.01 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00
Income Quality
1.35 -11.00 1.18
Currency in INR